Analysts: StemCells Inc (STEM.OQ)
STEM.OQ on NASDAQ Stock Exchange Capital Market
1.83USD
24 May 2013
1.83USD
24 May 2013
Price Change (% chg)
$-0.05 (-2.66%)
$-0.05 (-2.66%)
Prev Close
$1.88
$1.88
Open
$1.90
$1.90
Day's High
$1.90
$1.90
Day's Low
$1.82
$1.82
Volume
36,258
36,258
Avg. Vol
37,142
37,142
52-wk High
$2.66
$2.66
52-wk Low
$0.59
$0.59
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.16 | December | 25 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 3 | 2 | 3 | 3 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.75 | 1.67 | 1.75 | 1.75 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 4 | 0.23 | 0.30 | 0.08 | 0.81 |
| Quarter Ending Sep-13 | 4 | 0.23 | 0.30 | 0.08 | 0.84 |
| Year Ending Dec-13 | 4 | 0.96 | 1.20 | 0.51 | 2.75 |
| Year Ending Dec-14 | 4 | 1.05 | 1.60 | 0.30 | 2.40 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 4 | -0.16 | -0.12 | -0.21 | -0.28 |
| Quarter Ending Sep-13 | 4 | -0.17 | -0.13 | -0.21 | -0.28 |
| Year Ending Dec-13 | 4 | -0.65 | -0.54 | -0.78 | -0.90 |
| Year Ending Dec-14 | 4 | -0.56 | -0.43 | -0.77 | -1.04 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 0.29 | 0.28 | 0.00 | 1.05 |
| Quarter Ending Dec-12 | 0.31 | 0.21 | 0.10 | 32.44 |
| Quarter Ending Sep-12 | 0.43 | 0.26 | 0.16 | 38.06 |
| Quarter Ending Jun-12 | 0.55 | 0.25 | 0.30 | 54.67 |
| Quarter Ending Mar-12 | 0.33 | 0.64 | 0.31 | 95.15 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.13 | -0.17 | 0.04 | -27.53 |
| Quarter Ending Dec-12 | -0.14 | -0.07 | 0.07 | -48.79 |
| Quarter Ending Sep-12 | -0.14 | -0.54 | 0.40 | -280.28 |
| Quarter Ending Jun-12 | -0.25 | -0.22 | 0.03 | -12.00 |
| Quarter Ending Mar-12 | -0.26 | -0.45 | 0.19 | -73.08 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 0.23 | 0.23 | 0.27 | 0.28 | 0.81 |
| Quarter Ending Sep-13 | 0.23 | 0.23 | 0.26 | 0.28 | 0.84 |
| Year Ending Dec-13 | 0.96 | 0.97 | 1.06 | 1.43 | 2.75 |
| Year Ending Dec-14 | 1.05 | 1.07 | 1.16 | 1.87 | 2.40 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | -0.16 | -0.16 | -0.13 | -0.12 | -0.28 |
| Quarter Ending Sep-13 | -0.17 | -0.16 | -0.13 | -0.12 | -0.28 |
| Quarter Ending Dec-13 | -0.65 | -0.64 | -0.52 | -0.51 | -0.90 |
| Quarter Ending Dec-14 | -0.56 | -0.55 | -0.45 | -0.47 | -1.04 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 1 | 0 | 2 |
| Year Ending Dec-14 | 0 | 1 | 0 | 3 |
| Earnings | ||||
| Quarter Ending Jun-13 | 0 | 1 | 0 | 3 |
| Quarter Ending Sep-13 | 0 | 1 | 0 | 3 |
| Year Ending Dec-13 | 0 | 1 | 0 | 3 |
| Year Ending Dec-14 | 0 | 1 | 0 | 2 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$46.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates